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ABSTRACT  31 
In this case-control study, we investigated the seroprevalence and molecular evidence of 32 
Chlamydia trachomatis and Waddlia chondrophila in ectopic pregnancies (EP) and uneventful 33 
control (C) pregnancies in 343 women from Vietnam. Whereas presence of Chlamydia 34 
trachomatis IgG was strongly associated with EP (adjusted Odds Ratio [aOR] 5.41; 95% 35 
Confidence Intervals [95%CI] 2.58-11.32), its DNA remained undetected in all tubal lesions. We 36 
confirmed an independent association between antibodies against Waddlia and previous 37 
miscarriage (aOR 1.87, 95%CI 1.02-3.42). Further investigations are needed to understand the 38 
clinical significance of Waddlia high seroprevalence (25.9% in C) in this urban population. 39 
 40 
 41 
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SHORT REPORT 46 
Chlamydiae are obligate intracellular bacteria belonging to the Chlamydiales order 1. C. 47 
trachomatis is the most common bacterial cause of sexually transmitted infections worldwide 2. 48 
In women, 90% of C. trachomatis infections remain asymptomatic. However, if left untreated, 49 
chlamydial infection can lead to scarring of uterine tubes, PID (pelvic inflammatory disease), 50 
ectopic pregnancy and adverse pregnancy outcomes 2, 3. C.trachomatis induced pathogenesis is 51 
largely a result of chronic immunopathological reactions, most likely caused by persistent 52 
infections 3. 53 
Waddlia chondrophila, a Chlamydia-related bacterium, has recently been associated with both 54 
animal and human adverse pregnancy outcomes, such as miscarriage 2, 4-6. Its mode of 55 
transmission and pathogenesis remains to be explored.  56 
Since several Chlamydia spp. and Chlamydia-related bacteria colonize the cervicovaginal mucosa 57 
5-7, which may lead to tubal scarring and have been associated with adverse pregnancy outcomes 58 
in humans, we thus investigated their role in ectopic pregnancies. Ectopic pregnancy, a condition 59 
in which a fertilized egg settles and grows in a location other than the inner lining of the uterus, 60 
occurs in 2% of all pregnancies and remains the leading cause of pregnancy-related death in the 61 
first trimester of gestation 8, 9. 62 
A total of 347 patients were recruited at Tu Du Hospital, Hô Chi Minh City (Vietnam). The 63 
"Ectopic Pregnancy" group (EP) included 177 women with an ectopic pregnancy treated by 64 
laparoscopic salpingectomy. The "Control" group (C) included 166 women without any history 65 
of previous ectopic pregnancy and who experienced an uneventful pregnancy. Blood samples, 66 
fallopian tubes or placental biopsies were collected for each EP and C patient. Local ethical 67 
committees of both hospitals (clinical part in Vietnam & experimental part in Switzerland) 68 
approved the study protocol and all patients included in the study gave their written consent.  69 
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Serological status and epidemiological data were compared between patients with and without 70 
ectopic pregnancies, or between patients with and without Waddlia positive serology by the 71 
Pearson χ2 test (or the Fisher exact test when indicated) for categorical variables. For continuous 72 
variables, medians were compared by the Wilcoxon-Mann-Whitney test. Multivariate logistic 73 
regressions were performed to identify factors independently associated with ectopic pregnancies 74 
and miscarriages. All statistical analyses were performed using STATA 13.0 (Stata Corporation, 75 
College Station, USA). 76 
 77 
Sociodemographical data are presented in Table 1. All sera were tested for antibodies against 78 
Chlamydia trachomatis (Table 1), as previously described 1, 4, 6, 7, 10, 11. C. trachomatis IgG 79 
seroprevalence was 6.6% in the present Asian control population. Similar prevalence has been 80 
described by others 7, 12, 13. C. trachomatis seroprevalence was higher for women who 81 
experienced an ectopic pregnancy (24.9%) than for women with an uneventful pregnancy (6.6%, 82 
p<0.001).  83 
For Waddlia and other Chlamydia-related bacteria Micro-immunofluorescence (MIF) were 84 
performed as previously described 1, 4, 6. All immunofluorescence samples were read by two 85 
independent observers and only congruent results were considered positive. Sera that exhibited 86 
total immunoglobulin (Ig) titer ≥1:64 were tested for IgG and IgM reactivity using corresponding 87 
anti-human Fluorescein-labelled Ig (FluolineG or FluolineM, BioMerieux, Marcy l`Etoile, 88 
France) and serial two-fold dilutions of sera. Waddlia IgG and IgM positivity cut-offs were ≥1:64 89 
and ≥1:32, respectively 1. There was a significant association between total anti-Waddlia 90 
antibodies detected by microimmunofluorescence and ectopic pregnancy (p=0.04). However, 91 
there was no statistical association with EP when anti-Waddlia IgG, or anti-Waddlia IgM, were 92 
considered. Waddlia ELISA was performed as previously described 14 and confirmed the 93 
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association between Waddlia seropositivity and ectopic pregnancies (p=0.046). Serological 94 
evidence of human exposure to other Chlamydia-related bacteria, such as Parachlamydia 95 
acanthamoebae, Estrella lausannensis and Criblamydia sequanensis were not associated with 96 
ectopic pregnancies (Table 1). When all variables from Table 1 were considered (stepwise 97 
logistic regression analysis), the only three independent factors associated with ectopic pregnancy 98 
were a positive C. trachomatis serology (adjusted Odds Ratio [aOD] 5.41; 95% Confidence 99 
Intervals [95%CI] 2.58-11.31), number of sexual partners (aOR 9.34; 95%CI 1.95-44.66) and 100 
parity (aOR 2.69; 95%CI 1.94-3.75), which are well known risk factors for ectopic pregnancy 8, 9. 101 
Patients' characteristics according to their C. trachomatis serological status are shown in 102 
Supplementary Table 1. 103 
Women seropositive for Waddlia (n=100, 29.2%) were older (p=0.007) and experienced previous 104 
miscarriages more frequently (p=0.005) than Waddlia negative women (Table 2). Association 105 
between Waddlia seropositivity and miscarriage remains significant (aOR 1.87; 95%CI 1.02-106 
3.42) even after adjustment for age, parity, comorbidity and other serologies including C. 107 
trachomatis. There was no statistical association between Waddlia positive serology and medical 108 
comorbidities, gynaecological complaints during pregnancy, work status, number of lifelong 109 
sexual partners or presence of pets at home.  110 
There was no cross-reaction between Waddlia and C. trachomatis serologies, since 77 patients 111 
(23.1%) were positive only for Waddlia IgG and 37 (11.1%) were positive only for C. 112 
trachomatis IgG (Table 2). Only 18 patient (5.4%) were positive for both bacteria (p= 0.513). 113 
Presence of Waddlia15, 16 and/or C. trachomatis 7 DNA was tested in IgG positive patients. DNA 114 
extraction was performed from a 2-centimeter piece of fallopian tube (EP) or placental (C) tissue 115 
using Wizard SV genomic DNA purification kit (Promega Corporation, USA), and a pan-116 
Chlamydiales PCR was performed as previously described 17. This Pan-Chlamydiales PCR is 117 
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able to detect up to 5 DNA copies per reaction and demonstrated similar performance compared 118 
to specific Chlamydiales PCRs. Neither the 50 fallopian tubes nor the 43 placental samples with a 119 
positive Waddlia and/or C. trachomatis serology were positive for Waddlia or C.trachomatis 120 
DNA. All 20 control patients with a negative serology (10 from the "EP" group and 10 from the 121 
"C" group) were also negative by PCR.  122 
In summary, our data showed a strong association between C. trachomatis seropositivity and 123 
ectopic pregnancy. However, neither the fallopian tubes nor placenta of women with positive 124 
Chlamydia or Waddlia serologies demonstrated presence of respective bacteria, as also shown by 125 
others 12. Moreover, IgG but not IgM antibodies were detected during ectopic pregnancies. Thus, 126 
these results suggest that the persistence of the bacteria is not necessary to induce tubal damage, 127 
and reinforces the role of an immuno-pathological process due to a previous chlamydial infection 128 
18, 19. However, the physiopathology mechanism by which tubal scaring occurs without the 129 
presence of bacteria is not yet fully understood 12, 19.  130 
Waddlia IgG seroprevalence in the control group (25.9%) was higher than previously described 131 
in other asymptomatic patients: 14.6% in Switzerland 6, and 7.1% in London 4. This difference 132 
could be explained as a result of higher genetic susceptibility of Vietnamese to Waddlia infection 133 
or greater exposure to the yet unknown source of Waddlia infection 2, 4, 6. 134 
Whereas our study only identified a limited association of Waddlia with ectopic pregnancies 135 
(p=0.04), we observed a strong correlation between previous history of miscarriage and positive 136 
Waddlia serology (p=0.005). This was expected since Waddlia was previously reported as an 137 
abortigenic agent in both animal and human populations 2, 4-6, 19.  138 
A major limitation of the study was the absence of data concerning other potential confounding 139 
factors for ectopic pregnancy (i.e. other infectious agent) and miscarriage (i.e. chromosomal 140 
anomalies).  141 
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In conclusion, this study confirmed the serologic association of C. trachomatis with ectopic 142 
pregnancy 8 and of Waddlia with miscarriage 4, 6. Moreover, we showed an association between 143 
anti-Waddlia antibodies and ectopic pregnancy using both immunofluorescence and ELISA. 144 
Absence of C. trachomatis and W. chondrophila DNA in the fallopian tubes or placental tissues 145 
suggests that immunopathological mechanisms rather than bacterial infection are involved in 146 
ectopic pregnancy. Further investigations are needed to understand the high prevalence of 147 
Waddlia in this Asian population and to precise its role in ectopic pregnancy. 148 
149 
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Characteristics Control Ectopic pregnancy p value
(n=166) (n=177)
Age in years (years + SD) 28 + 5.2 30.3 + 6.4 0.0003
> 40 6 (3.6%) 17 (9.6%) 0.031
Nulliparity 111 (66.9%) 72 (40.7%) <0.001
Comorbidity 19 (11.5%) 7 (4%) 0.013
Pets at home 53 (31.93%) 54 (30.51%) 0.777
Lifelong sexual partners (>2) 2 (1.2%) 12 (6.8%) 0.012
Chlamydia trachomatis  ELISA*
Negative 153 (92.2%) 126 (71.2%) <0.0001
Positive 11 (6.6%) 44 (24.9%)
Doubtful** 2 (1.2%) 7 (4%)
Waddlia MIF
Total Ig > 1/64 49 (29.5%) 71 (40.1%) 0.04
IgG > 1/64 43 (25.9%) 57 (32.2%) 0.2
IgM > 1/32 2 (1.2%) 3 (1.7%) 1
Waddlia  ELISA OD 0.35 + 0.097 0.371 + 0.092 0.046
Parachlamydia  IgG MIF 10 (6.0%) 19 (10.7%) 0.125
Estrella  IgG MIF 21 (12.7%) 35 (19.8%) 0.081
Criblamydia IgG MIF 4 (2.4%) 5 (2.8%) 1.0
Table 1: Sociodemographical data and serologies according to pregnancy outcome.  236 
* MOMP-R, CT pELISA (R-Biopharm, Darmstadt, Germany) 237 
** Similar p-value when doubtful were excluded 238 
OD: optical density 239 
MIF: micro-immunofluorescence 240 
 241 
 242 
 243 
 244 
 245 
 246 
 247 
 248 
 249 
 250 
 251 
 252 
 253 
 254 
 255 
 256 
 257 
 258 
259 
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Characteristics Waddlia  IgG Waddlia  IgG p value
negative positive
(n= 243) (n=100)
Age in years (years + SD) 28.7 + 5.7 30.4 + 6.3 0.02
> 40 10 (4.1%) 13 (13%) 0.007
Nulliparity 137 (56.4%) 46 (46%) 0.08
Previous miscariage 34 (14%) 24 (24%) 0.005
Comorbidity 18 (7.4%) 7 (7%) 1
Pets at home 166 (68.31%) 70 (70%) 0.759
Lifelong sexual partners (>2) 11 (4.5%) 3 (3%) 0.765
Chlamydia trachomatis  ELISA 37 (15.2%) 18 (18%) 0.513
Parachlamydia  IgG MIF 19 (7.8%) 10 (10%) 0.525
Estrella  IgG MIF 38 (15.6%) 18 (18%) 0.63
Criblamydia IgG MIF 5 (2.1%) 4 (4%) 0.292
Table 2: Patient`s characteristics according to their Waddlia serological status 260 
 261 
 262 
 263 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
 271 
 272 
 273 
 274 
 275 
 276 
 277 
278 
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Characteristics C.trachomatis  IgG C.trachomatis  IgG p value
negative positive
(n= 279) (n=55)
Age in years (years + SD) 29.2 + 5.8 29.4 + 6.5 0.768
> 40 16 (5.7%) 6 (10.9%) 0.228
Nulliparity 126 (45.2%) 29 (52.7%) 0.375
Previous miscariage 40 (14.3%) 15 (27.3%) 0.027
Comorbidity 21 (7.9%) 3 (5.5%) 0.778
Pets at home 82 (29.4%) 22 (40%) 0.151
Lifelong sexual partners (>2) 12 (4.3%) 2 (3.6%) 1
Waddlia IgG MIF 77 (27.6%) 18 (32.7%) 0.513
Parachlamydia  IgG MIF 24 (8.6%) 5 (9.1%) 1.0
Estrella  IgG MIF 36 (12.9%) 15 (27.3%) 0.012
Criblamydia IgG MIF 6 (2.2%) 3 (5.5%) 0.171
Supplementary Table 1: Patient`s characteristics according to their C. trachomatis serological 279 
status. C. trachomatis doubtful results were excluded from the analysis. 280 
 281 
 282 
 283 
 284 
 285 
 286 
 287 
 288 
 289 
 290 
 291 
 292 
 293 
 294 
 295 
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ANNEX 
METHOD 
Subject  
A total of 343 patients were recruited at Tu Du Hospital, Hô Chi Minh (Vietnam) in 2007. The 
"Ectopic pregnancy" group (EP) included 177 women with an ectopic pregnancy which was 
treated by laparoscopy. The "Control" group (C) included 166 women who experienced a normal 
pregnancy, without any history of previous ectopic pregnancy, preterm labor or miscarriage. One 
blood sample, respectively affected fallopian tube or placental biopsy were collected for each EP 
and C patient. Local ethical committees of both hospitals have approved the study protocol and 
all patients included in the study gave their written consent.  
All blood samples have been centrifuged as soon as possible and only sera have been kept and 
stored frozen (at - 20 C). Both ectopic pregnancy product and placenta have also been stored 
frozen (at -20 C). Each sample has been anonymized with a code, according to the patient’s 
group. (EP1, EP2, EP3,… for ectopic pregnancies or C1, C2, C3, … for controls) 
For each patient, a case report form has been filled to investigate for potential risk factors (date of 
birth, number of pregnancies, number of children, animals at home, number of previous sexual 
partner,...). 
All the samples collected at Tu Du Hospital (Vietnam) have been sent by express frozen courier 
to the CHUV (Lausanne, Switzerland) where the experimental part of this research has been 
performed. Local ethical committees of both hospitals have approved the study protocol and all 
patients included in the study gave their written consent. 
 
 
 
W. chondrophila and C. trachomatis micro-immunofluorescence assay 
Immunofluorescence test were performed by using W. chondrophila strain ATCC VR-1470 as 
antigen1. All immunofluorescence were read blindly by two independent observers and only 
congruent results were considered positive. Sera that exhibited total immunoglobulin (Ig) titer ≥ 
1:64 were tested for IgG and IgM reactivity using corresponding anti-human Ig flourescein 
(FluolineG or FluolineM, BioMerieux, Marcy l`Etoile, France) and serial two-fold dilutions of 
serum. IgG and IgM positivity cut-offs were ≥ 1:64 and ≥ 1:32, respectively, as proposed for 
other chlamydia-like organisms. The sera collected for a previous study from two women 
identified to be positive, respectively negative, for chlamydia were used as positive and negative 
controls2. All sera were also tested for IgG antibodies against Chlamydia trachomatis with the 
MOMP-R, CT pELISA (R-biopharm, Darmstadt, Germany). These ELISA use a recombinant 
peptid of the major outer membrane protein (MOMP) of C.trachomatis and showed a good 
sensitivity/specificity ratio in previous studies3. 
DNA extraction and PCR 
DNA extraction was performed for Women with Waddlia chondrophila IgG title > 1:64.  
Practically, a two centimeter piece of ectopic or placental tissue was dissected and DNA 
extraction was performed using Wizard SV genomic DNA purification kit (Promega Corporation, 
USA). 
A PAN-CHLAM was performed on the DNA extract from ectopic or placental tissues for the 
women with an IgG title > 1:64 in order to correlate a positive serology against Waddlia with the 
presence of this bacterium in the tissues4. This Pan-Chlamydiales PCR is able to detect up to 5 
DNA copies per reaction and demonstrated similar performance compared to specific 
Chlamydiales PCRs. 
 
Waddlia chondrophila ELISA 
ELISA was performed for Waddlia chondrophila based on a recent study protocol5. 
Statistical analysis 
Serological status and epidemiological data were compared between patients with and without 
ectopic pregnancies, or between patients with and without Waddlia positive serology by the 
Pearson χ2 test (or the Fisher exact test when indicated) for categorical variables. For continuous 
variables, medians were compared by the Wilcoxon-Mann-Whitney test. Multivariate logistic 
regressions were performed to identify factors independently associated with ectopic pregnancies 
and miscarriages. All statistical analyses were performed using STATA 13.0 (Stata Corporation, 
College Station, USA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
1. Socio-demographic data and pregnancy outcomes: 
Women experienced ectopic pregnancy (n=177) were compared with women experienced an 
uneventful pregnancy (n=166) according to their epidemiological information (Table 1). Risks 
factors for an ectopic pregnancy were maternal age (p = 0.031), parity (p < 0.001) and number of 
sexual partner (p=0.012). They were no statistical difference between our two groups in term of 
medical comorbidity, gynecological complains during pregnancy, work activity or animal 
possession.  
When all variables from Table 1 were considered (stepwise logistic regression analysis), the only 
three independent factors associated with ectopic pregnancy were a positive C. trachomatis 
serology (adjusted Odds Ratio [aOD] 5.41; 95% Confidence Intervals [95%CI] 2.58-11.31), 
number of sexual partners (aOR 9.34; 95%CI 1.95-44.66) and parity (aOR 2.69; 95%CI 1.94-
3.75) 
2. Chlamydial serologies:  
Waddlia chondrophila : 
There was a borderline significant association between total anti-Waddlia antibodies There was a 
significant association between total anti-Waddlia antibodies detected by 
microimmunofluorescence and ectopic pregnancy (p=0.04). However, there was no statistical 
association with EP when anti-Waddlia IgG, or anti-Waddlia IgM, were considered. Waddlia 
ELISA was performed as previously described 14 and confirmed the association between Waddlia 
seropositivity and ectopic pregnancies (p=0.046).  and ectopic pregnancy  (p=0.04 ; Table 2). 
However, there was no statistical difference when anti-Waddlia IgG or IgM were considered. A 
total of 36 and 5 women exhibited high anti-Waddlia IgG titers > 1/256 and anti-Waddlia IgM  > 
1/32, respectively. Waddlia ELISA and confirm the borderline association between Waddlia 
seropositivity and ectopic pregnancies (p=0.046). 
Women positive for Waddlia (n=100, 29.2%) were older (p= 0.007) and experienced previous 
miscarriages more frequently (p=0.005) than Waddlia negative women (Table 2). They were no 
statistical difference between both groups in terms of medical comorbidity, gynecological 
complains during pregnancy, work activity, lifelong sexual partner or presence of pets at home.  
Chlamydia trachomatis and other Chlamydia related bacteria : 
C.trachomatis seroprevalence (Table 1) was higher for women who experienced an ectopic 
pregnancy (24.9%) than for women with an uneventful pregnancy (6.6%, p < 0.001). Serological 
evidence of human exposure to other Chlamydia-like organisms, such as Parachlamydia 
acanthamoebae (p=0.125), Estrella lausannensis (p=0.081), Criblamydia sequanensis (p=0.187) 
were not associated with ectopic pregnancies. 
There was no cross-reaction between Waddia and C.trachomatis serologies, since 77 patients 
(23.1%) were positive only for Waddlia IgG and 37 (11.1%) positives only for C.trachomatis 
IgG. Only 18 patient (5.4%) were positive for both bacteria (p= 0.512). 
3. Tissues identification of bacteria : 
None of the 50 Fallopian tube and 43 placenta with a positive Waddlia and/or C.trachomatis 
serology demonstrated presence of Waddlia or Chlamydia DNA. All 20 control patients with a 
negative serology (10 EP and 10 C) were also negative by PCR. 
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